Skip to main content

Table 1 Details of studies included in the meta-analysis

From: Oncological outcomes of anatomic versus non-anatomic resections for small hepatocellular carcinoma: systematic review and meta-analysis of propensity-score matched studies

First author/year

Country

Population Selection

Variables matched

Total Sample

AR

NAR

NOS Score

Cho 2019 [14]

Korea

Small solitary HCC with MVI (< 5 cm)

Age; sex; albumin; AST; ALT; tumor size; vascular invasion; operating time; blood loss

118

59

59

8

Cucchetti 2014 [7]

Italy-China

Child A; early HCC; surgical margin ≥ 1 cm; Single nodule < 5 cm or up to 3 nodules < 3cm

Age; HCV; HbsAg; albumin; MELD score; solitary tumors; size; G3-G4; MVI

298

149

149

7

Haruki 2021 [8]

Japan

Small solitary HCC (< 5cm)

Age; sex; HBV; HCV; ICG-R15; Child-Pugh grade; tumor size; AFP; tumor number

132

66

66

8

Hokuto 2018 [9]

Japan

Extended to a depth of < 3 cm from the liver surface and measured < 5cm in diameter

Age; Gender; HBsAg; HCV-Ab; AFP; DCP; AST; ALT; albumin; operation time; tumor size; microvascular invasion

40

20

20

8

Ishii 2014 [10]

Japan

HCC patients undergoing hepatectomy

Age; gender; albumin; bilirubin; PT; size; Tumor number; Operation time; blood loss

88

44

44

7

Kaibori 2017 [11]

Japan

Curative resection; Solitary tumor ≤ 5cm; ICG-R15 ≤ 15%;

Age; HCV; HBV; bilirubin; ALT; albumin; PLT; ICG-R15; AFP; blood loss; operative time; size; MVI

710

355

355

8

Kwon 2022 [13]

Korea

Curative resection; Solitary tumor ≤ 5cm

Age; sex; HBV; HCV; Child-Pugh grade; PLT; total bilirubin; ICG-R15

341

224

117

7

Minagawa 2022 [12]

Japan

Solitary HCC (≤ 5cm)

Age; sex; HBV; HCV; total bilirubin; AST; ALT

134

67

67

8

  1. HCV hepatitis C virus, HBV hepatitis B virus, MVI microvascular invasion, PT prothrombin time, PLT platelet count, AFP alpha-fetoprotein, ALT alanine-aminotransferase, AST aspartate-aminotransferase, ICG-R15 Indocyanine Green Retention Test at 15 min, DCP Des-gamma-carboxy prothrombin, MELD model for end-stage liver disease, AR anatomic resection, NAR non-anatomic resection